Page 4

3.2.3. Threats of Substitutes 3.2.4. Threats of New Entrants 3.2.5. Degree of Competition 3.3. PESTLE Analysis 3.3.1. Political 3.3.2. Economical 3.3.3. Social 3.3.4. Technological 3.3.5. Legal 3.3.6. Environmental 3.4. SWOT Analysis 3.4.1. Strengths 3.4.2. Weakness 3.4.3. Opportunities 3.4.4. Threats 3.5. Y-O-Y Analysis CHAPTER 4 MARKET DYNAMICS 4.1. Market Drivers 4.1.1. Growing Acceptance for Biopharmaceuticals 4.1.2. Ability of Biopharmaceuticals to Treat Previously Untreatable Diseases 4.1.3. Huge Market Demand 4.2. Market Restraints 4.2.1. Rising Demand for Affordable Biopharmaceuticals 4.2.2. High-end Manufacturing Requirements 4.2.3. Complicated and Cumbersome Regulatory Requirements 4 .3. Market Opportunities 4.4. Market Challenges CHAPTER 5 BIOPHARMACEUTICALS MARKET – BY PRODUCT TYPE 5.1. Monoclonal Antibodies 5.1.1. Anti Cancer Monoclonal Antibodies 5.1.2. Anti-inflammatory Monoclonal Antibodies 5.1.3. Other Monoclonal Antibodies 5.2. Recombinant Growth Factors 5.2.1. Erythropoietin 5.2.2. Granulocyte Colony Stimulating Factor 5.3. Purified Proteins 5.3.1. Leukemia Inhibitory Factor LIF 5.3.2. P53 Protein

Profile for william joe

Biopharmaceuticals Market analysis and forecast  

In 2018, the global biopharmaceuticals market was valued at USD 237,250.8 million and is estimated at USD 388,997.3 million in 2024, a CAGR...

Biopharmaceuticals Market analysis and forecast  

In 2018, the global biopharmaceuticals market was valued at USD 237,250.8 million and is estimated at USD 388,997.3 million in 2024, a CAGR...

Profile for willjo936
Advertisement